Gehl H B, Vorwerk D, Klose K C, Günther R W
Department of Diagnostic Radiology, Technical University Aachen, Germany.
Radiology. 1991 Aug;180(2):337-9. doi: 10.1148/radiology.180.2.1906189.
Enhancement of the pancreas was demonstrated after low-dose (10 mumol/kg) infusion of a new contrast agent for magnetic resonance (MR) imaging, manganese dipyridoxal-diphosphate (Mn-DPDP). To the authors' knowledge, this has not been described previously. The enhancement reached a maximum of 98% +/- 13% (standard deviation) during a long period (greater than 6 hours). Mn-DPDP seems to have potential as a selective contrast agent in MR imaging of the pancreas.
在静脉注射低剂量(10 μmol/kg)新型磁共振成像造影剂二磷酸二吡啶甲醛锰(Mn-DPDP)后,胰腺出现强化。据作者所知,此前尚无此类报道。在长达6小时以上的时间里,强化程度最高达到98%±13%(标准差)。Mn-DPDP似乎有潜力成为胰腺磁共振成像的一种选择性造影剂。